LEADER 01740nam  2200361   450 
001 9910729797403321
005 20230728214251.0
035   $a(CKB)4960000000468870
035   $a(NjHacI)994960000000468870
035   $a(EXLCZ)994960000000468870
100   $a20230728d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAdvances in Pathogenesis and Therapeutics of Hepatobiliary Diseases /$fJinghua Wang
210  1$a[Place of publication not identified] :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2023.
215   $a1 online resource (190 pages)
311   $a3-0365-7738-6 
330   $aThe Special Issue of Biomedicines, entitled "Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases," presents cutting-edge research findings, innovations, and insights into a wide range of topics related to the hepatobiliary system, such as the molecular mechanisms underlying disease pathogenesis, diagnostic advancements, novel therapeutic approaches, and prevention strategies. The Special Issue comprises seven original articles and four review articles regarding NAFLD, primary biliary cholangitis (PBC), hepatitis B and C, and hepatocellular carcinoma (HCC).
606   $aBacterial diseases$xPathogenesis
606   $aBacterial diseases
615  0$aBacterial diseases$xPathogenesis.
615  0$aBacterial diseases.
676   $a616.014
700   $aWang$b Jinghua$01376999
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910729797403321
996   $aAdvances in Pathogenesis and Therapeutics of Hepatobiliary Diseases$93413461
997   $aUNINA